Status:
UNKNOWN
Collection of the Thrombo-VaxCov Cohort
Lead Sponsor:
University Hospital, Lille
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Brief Summary
In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation. This study collect clinical and biological data of all atypica...
Detailed Description
In the context of anti-Covid19 vaccination, atypical thrombosis have occurred and potential links with vaccination is under investigation. In France, the study collect clinical and biological data of ...
Eligibility Criteria
Inclusion
- atypical thrombosis symptoms onset within 4 weeks of vaccination
Exclusion
- children
Key Trial Info
Start Date :
April 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04889326
Start Date
April 2 2021
End Date
May 1 2023
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU lille
Lille, France, 59037